Literature DB >> 33712035

Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?

Cecilia Söderberg-Nauclér1.   

Abstract

The majority of people infected with SARS-CoV-2 are asymptomatic or have mild to moderate symptoms. However, for unknown reasons, about 15 % have severe pneumonia requiring hospital care and oxygen support, and about 5 % develop acute respiratory distress syndrome, septic shock, and multiorgan failure that result in a high mortality rate. The risk of severe COVID-19 is highest among those who are over 70 years of age. Why severe COVID-19 develops in some people but not others is not understood. Could some cases involve reactivation of latent cytomegalovirus (CMV)?

Entities:  

Year:  2021        PMID: 33712035      PMCID: PMC7952506          DOI: 10.1186/s12979-021-00218-z

Source DB:  PubMed          Journal:  Immun Ageing        ISSN: 1742-4933            Impact factor:   6.400


  72 in total

1.  Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study.

Authors:  Anders Wikby; Boo Johansson; Jadwiga Olsson; Sture Löfgren; Bengt Olof Nilsson; Frederick Ferguson
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

2.  Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation.

Authors:  Afsar Rahbar; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 3.  Management of cytomegalovirus infection and disease after solid-organ transplantation.

Authors:  W van der Bij; R Speich
Journal:  Clin Infect Dis       Date:  2001-07-01       Impact factor: 9.079

4.  Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.

Authors:  Mohamed Zuhair; G Suzanne A Smit; Gabriel Wallis; Faiz Jabbar; Colette Smith; Brecht Devleesschauwer; Paul Griffiths
Journal:  Rev Med Virol       Date:  2019-01-31       Impact factor: 6.989

5.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

6.  Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines.

Authors:  Svetlana Dmitrienko; Robert Balshaw; Gerardo Machnicki; R Jean Shapiro; Paul A Keown
Journal:  Transplantation       Date:  2009-02-27       Impact factor: 4.939

7.  Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.

Authors:  S F Atabani; C Smith; C Atkinson; R W Aldridge; M Rodriguez-Perálvarez; N Rolando; M Harber; G Jones; A O'Riordan; A K Burroughs; D Thorburn; J O'Beirne; R S B Milne; V C Emery; P D Griffiths
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

8.  Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.

Authors:  Xi Li; Yongbo Huang; Zhiheng Xu; Rong Zhang; Xiaoqing Liu; Yimin Li; Pu Mao
Journal:  BMC Infect Dis       Date:  2018-06-28       Impact factor: 3.090

Review 9.  Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.

Authors:  Brian P McSharry; Selmir Avdic; Barry Slobedman
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

10.  Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients.

Authors:  Pierre Le Balc'h; Kieran Pinceaux; Charlotte Pronier; Philippe Seguin; Jean-Marc Tadié; Florian Reizine
Journal:  Crit Care       Date:  2020-08-28       Impact factor: 9.097

View more
  14 in total

1.  Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals.

Authors:  Norihide Jo; Rui Zhang; Hideki Ueno; Takuya Yamamoto; Daniela Weiskopf; Miki Nagao; Shinya Yamanaka; Yoko Hamazaki
Journal:  Front Aging       Date:  2021-08-10

2.  CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.

Authors:  Shourjo Chakravorty; Adam B Cochrane; Mitchell A Psotka; Anil Regmi; Lauren Marinak; Amy Thatcher; Oksana A Shlobin; A Whitney Brown; Christopher S King; Kareem Ahmad; Vikramjit Khangoora; Anju Singhal; Steven D Nathan; Shambhu Aryal
Journal:  Transplant Direct       Date:  2022-06-10

Review 3.  The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections.

Authors:  Fanny Martini; Eric Champagne
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

4.  Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.

Authors:  Dore C Ananthegowda; Mohamad Y Khatib; Husain S Ali; Mohamed Al Wraidat; Yahia Imam
Journal:  IDCases       Date:  2021-11-23

5.  Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease.

Authors:  Sarita Rani Jaiswal; Jaganath Arunachalam; Ashutosh Bhardwaj; Ashraf Saifullah; Rohit Lakhchaura; Mayank Soni; Gitali Bhagawati; Suparno Chakrabarti
Journal:  Clin Transl Immunology       Date:  2022-01-11

6.  Risk factors for Herpes simplex virus (HSV) and Cytomegalovirus (CMV) infections in critically-ill COVID-19 patients.

Authors:  Kristina E Fuest; Johanna Erber; Wiebke Berg-Johnson; Markus Heim; Dieter Hoffmann; Barbara Kapfer; Silja Kriescher; Bernhard Ulm; Roland M Schmid; Sebastian Rasch; Tobias Lahmer
Journal:  Multidiscip Respir Med       Date:  2022-03-01

Review 7.  How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.

Authors:  Ludmila Müller; Svetlana Di Benedetto
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

8.  Recent Advances in Unveiling the Role of Beta-Herpesviruses in Autoimmune Diseases.

Authors:  Maria Cristina Arcangeletti; Elisabetta Caselli
Journal:  Microorganisms       Date:  2021-12-13

Review 9.  Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.

Authors:  Ranim El Baba; Georges Herbein
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

Review 10.  Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV.

Authors:  Léna Royston; Stéphane Isnard; John Lin; Jean-Pierre Routy
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.